The virtual cancer clinic has closed its seed round which will support the company’s plans to expand its AI-powered, multidisciplinary virtual cancer clinic.
Virtual cancer clinic Perci Health has successfully raised £7.7 million funding, after closing a new £3 million round and doubling the original £1.5m target.
This includes a £295,000 investment from Macmillan Cancer Support, further solidifying the charity’s belief in Perci Health’s mission to transform cancer care. Guinness Ventures and Conduit Fund have joined existing investors Octopus Ventures and 35 of the UK’s leading oncologists and cancer surgeons in backing Perci Health.
The new funds will support the company’s plans to expand its AI-powered, multidisciplinary virtual cancer clinic, reaching more individuals and healthcare providers across the UK.
In March, Healthcare Today reported that Macmillan Cancer Support had taken a stake in the company.
“This investment will allow us to continue pioneering a model of care that integrates digital innovation with compassionate, specialist-led support, providing better outcomes for everyone living with and beyond cancer,” said co-founder and chief executive Kelly McCabe.
UK cancer outcomes lag
Macmillan estimates that there are currently almost 3.5 million people living with cancer in the UK and this number will continue to rise, creating an urgent need for new, effective ways to support patients. As more people are diagnosed with cancer at younger ages and survival rates improve, there is a growing population of working-age people who need ongoing support to stay in or return to work after treatment.
In the UK, cancer outcomes lag up to 25 years behind European peers, with 41% of staged diagnoses being at a late stage in England and around a third of eligible people missing critical screening appointments for breast, bowel and cervical cancer.
Improving these outcomes will require collaboration across the government, NHS, private insurers, charities, and employers, and Perci Health’s model addresses these gaps by offering comprehensive care that spans prevention, early detection, treatment navigation, symptom management, and survivorship care.
“We’re incredibly impressed by the way Perci Health is tackling the gaps in cancer care with a human-first, tech-enabled model,” said Chantal Cox, investor at Octopus Ventures. “This approach not only addresses pressing healthcare needs but also delivers measurable impact in terms of both clinical outcomes and cost-efficiency, which is vital for scaling the model across more insurers, employers, and health systems.”
